Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool
- 1Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel
- 2Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
- 3Department of Biosciences, University of Helsinki, Helsinki, Finland
- 4Departments of Neuroscience and Neurosurgery, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
by Zega, K., Jovanovic, V. M., Vitic, Z., Niedzielska, M., Knaapi, L., Jukic, M. M., et al. (2017). Front. Mol. Neurosci. 10:372. doi: 10.3389/fnmol.2017.00372
An author name was incorrectly spelled as Roland F. Friedel. The correct spelling is Roland H. Friedel. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: DUSP16, hydrocephalus, brain overgrowth, megalencephaly, macrocephaly, neurogenesis, neural differentiation, neuronal progenitors
Citation: Zega K, Jovanovic VM, Vitic Z, Niedzielska M, Knaapi L, Jukic MM, Partanen J, Friedel RH, Lang R and Brodski C (2018) Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool. Front. Mol. Neurosci. 11:29. doi: 10.3389/fnmol.2018.00029
Received: 12 January 2018; Accepted: 23 January 2018;
Published: 01 February 2018.
Edited and reviewed by: Hermona Soreq, Hebrew University of Jerusalem, Israel
Copyright © 2018 Zega, Jovanovic, Vitic, Niedzielska, Knaapi, Jukic, Partanen, Friedel, Lang and Brodski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Claude Brodski, email@example.com
†Present Address: Marin M. Jukic, Pharmacogenetics Section, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden